Skip to content

Cooper Companies, Inc.

COO· NasdaqCore metricsCIK 711404

Ophthalmic goods7 peers

Last sale
Nov 12, 2026 · -1.14%
Market cap
$11.83B
190.16M shares
Filings
1,022
$1.07B
Q3 2026+5.1% FY25 yoy
$432.80M
Q3 2026−4.4% FY25 yoy
$222.00M
Q3 2026−3.2% FY25 yoy
$528.10M
Q3 2026derived+50.5% FY25 yoy
$2.24
Q3 2026−4.6% FY25 yoy
$154.70M
Q3 2026+2.8% FY25 yoy
$11.83B
20.7×
2.8×
1.4×
5.73%
—

Twelve months to Jul 31, 2026 · derived

Price

$62.2013.30%$9.54past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of record

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$4.09BFY 2025
$4.09B0FY 2014FY 2019FY 2025
PeriodEndedValueKindSource trail
FY 20252025-10-31$4,092,400,000reported
FY 20242024-10-31$3,895,400,000reported
FY 20232023-10-31$3,593,200,000reported
FY 20222022-10-31$3,308,400,000reported
FY 20212021-10-31$2,922,500,000reported
FY 20202020-10-31$2,430,900,000reported
FY 20192019-10-31$2,653,400,000reported
FY 20182018-10-31$2,532,800,000reported
FY 20172017-10-31$2,139,000,000reported
FY 20162016-10-31$1,966,800,000reported
FY 20152015-10-31$1,797,100,000reported
FY 20142014-10-31$1,717,776,000reported

Capital returns

Dividends and buybacks · FY2016 to FY2025
Fiscal yearDividendsBuybacksTotalPer shareSharesShares · yoyof free cash flow
FY2025$0.00$290.10M$290.10M—195.98M sh−1.8%66.9%
FY2024$0.00$0.00$0.00—199.58M sh+303.0%0.0%
FY2023$3.00M$0.00$3.00M$0.0149.53M sh+0.3%1.4%
FY2022$3.00M$78.50M$81.50M$0.0149.35M sh−0.1%18.1%
FY2021$3.00M$24.80M$27.80M$0.0349.41M sh+0.6%5.3%

Segments

Revenue by Segments, FY2019 to FY2025FY2019Coopervision Segment · FY2019 · $1.97BCoopersurgical Segment · FY2019 · $680.50MFY2020Coopervision Segment · FY2020 · $1.84BCoopersurgical Segment · FY2020 · $587.90MFY2021CooperVision · FY2021 · $2.15BCoopervision Segment · FY2021 · $2.15BCooperSurgical · FY2021 · $770.50MCoopersurgical Segment · FY2021 · $770.50MFY2022CooperVision · FY2022 · $2.24BCoopervision Segment · FY2022 · $2.24BCooperSurgical · FY2022 · $1.07BCoopersurgical Segment · FY2022 · $1.07BFY2023CooperVision · FY2023 · $2.42BCoopervision Segment · FY2023 · $2.42BCooperSurgical · FY2023 · $1.17BCoopersurgical Segment · FY2023 · $1.17BFY2024CooperVision · FY2024 · $2.61BCoopervision Segment · FY2024 · $2.61BCooperSurgical · FY2024 · $1.29BCoopersurgical Segment · FY2024 · $1.29BFY2025CooperVision · FY2025 · $2.74BCoopervision Segment · FY2025 · $2.74BCooperSurgical · FY2025 · $1.35BCoopersurgical Segment · FY2025 · $1.35B
LineFY2025ShareChange
CooperVision$2.74B67%+5.2%
Coopervision Segment$2.74B67%+5.2%
CooperSurgical$1.35B33%+4.9%
Coopersurgical Segment$1.35B33%+4.9%
Total$4.09B

From the 10-K filed Dec 5, 2025COO

Ophthalmic goods

Cooper Companies, Inc. is the 3rd largest of the 8 covered companies the SEC files under this code, by revenue. SIC 3851

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Cooper Companies, Inc. · CIK 711404 · Engraved from SEC EDGAR